336 related articles for article (PubMed ID: 22371007)
1. The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway.
Liberal R; Grant CR; Holder BS; Ma Y; Mieli-Vergani G; Vergani D; Longhi MS
Hepatology; 2012 Aug; 56(2):677-86. PubMed ID: 22371007
[TBL] [Abstract][Full Text] [Related]
2. T-regs in autoimmune hepatitis-systemic lupus erythematosus/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile.
Longhi MS; Ma Y; Grant CR; Samyn M; Gordon P; Mieli-Vergani G; Vergani D
J Autoimmun; 2013 Mar; 41():146-51. PubMed ID: 23287048
[TBL] [Abstract][Full Text] [Related]
3. Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis.
Longhi MS; Meda F; Wang P; Samyn M; Mieli-Vergani G; Vergani D; Ma Y
Hepatology; 2008 Feb; 47(2):581-91. PubMed ID: 18220288
[TBL] [Abstract][Full Text] [Related]
4. Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis.
Grant CR; Liberal R; Holder BS; Cardone J; Ma Y; Robson SC; Mieli-Vergani G; Vergani D; Longhi MS
Hepatology; 2014 Mar; 59(3):1007-15. PubMed ID: 23787765
[TBL] [Abstract][Full Text] [Related]
5. Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis.
Longhi MS; Hussain MJ; Kwok WW; Mieli-Vergani G; Ma Y; Vergani D
Hepatology; 2011 Feb; 53(2):536-47. PubMed ID: 21274874
[TBL] [Abstract][Full Text] [Related]
6. HCV-infected hepatocytes drive CD4+ CD25+ Foxp3+ regulatory T-cell development through the Tim-3/Gal-9 pathway.
Ji XJ; Ma CJ; Wang JM; Wu XY; Niki T; Hirashima M; Moorman JP; Yao ZQ
Eur J Immunol; 2013 Feb; 43(2):458-67. PubMed ID: 23161469
[TBL] [Abstract][Full Text] [Related]
7. The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.
Ju Y; Shang X; Liu Z; Zhang J; Li Y; Shen Y; Liu Y; Liu C; Liu B; Xu L; Wang Y; Zhang B; Zou J
Mol Immunol; 2014 Mar; 58(1):85-91. PubMed ID: 24333756
[TBL] [Abstract][Full Text] [Related]
8. Hepatocytes paradoxically affect intrahepatic IFN-γ production in autoimmune hepatitis due to Gal-9 expression and TLR2/4 ligand release.
Mo R; Feng XX; Wu YN; Wang H; He YP; Sun HH; Guo F; Chen Q; Yan W; Li PY; Liu M; Zhang GM; Tian DA; Feng ZH
Mol Immunol; 2020 Jul; 123():106-115. PubMed ID: 32485469
[TBL] [Abstract][Full Text] [Related]
9. Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis.
Longhi MS; Ma Y; Mitry RR; Bogdanos DP; Heneghan M; Cheeseman P; Mieli-Vergani G; Vergani D
J Autoimmun; 2005 Aug; 25(1):63-71. PubMed ID: 16005184
[TBL] [Abstract][Full Text] [Related]
10. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis.
Ferri S; Longhi MS; De Molo C; Lalanne C; Muratori P; Granito A; Hussain MJ; Ma Y; Lenzi M; Mieli-Vergani G; Bianchi FB; Vergani D; Muratori L
Hepatology; 2010 Sep; 52(3):999-1007. PubMed ID: 20683931
[TBL] [Abstract][Full Text] [Related]
11. Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells.
Wang F; Wan L; Zhang C; Zheng X; Li J; Chen ZK
Immunobiology; 2009; 214(5):342-9. PubMed ID: 19362679
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis.
Grant CR; Holder BS; Liberal R; Heneghan MA; Ma Y; Mieli-Vergani G; Vergani D; Longhi MS
Clin Exp Immunol; 2017 Jul; 189(1):71-82. PubMed ID: 28257599
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of interleukin-17 promotes differentiation of CD25⁻ cells into stable T regulatory cells in patients with autoimmune hepatitis.
Longhi MS; Liberal R; Holder B; Robson SC; Ma Y; Mieli-Vergani G; Vergani D
Gastroenterology; 2012 Jun; 142(7):1526-35.e6. PubMed ID: 22387392
[TBL] [Abstract][Full Text] [Related]
14. FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency.
Peiseler M; Sebode M; Franke B; Wortmann F; Schwinge D; Quaas A; Baron U; Olek S; Wiegard C; Lohse AW; Weiler-Normann C; Schramm C; Herkel J
J Hepatol; 2012 Jul; 57(1):125-32. PubMed ID: 22425700
[TBL] [Abstract][Full Text] [Related]
15. Tim-3 suppresses autoimmune hepatitis via the p38/MKP-1 pathway in Th17 cells.
Wu H; Tang S; Zhou M; Xue J; Yu Z; Zhu J
FEBS Open Bio; 2021 May; 11(5):1406-1416. PubMed ID: 33728805
[TBL] [Abstract][Full Text] [Related]
16. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.
Biagi E; Di Biaso I; Leoni V; Gaipa G; Rossi V; Bugarin C; Renoldi G; Parma M; Balduzzi A; Perseghin P; Biondi A
Transplantation; 2007 Jul; 84(1):31-9. PubMed ID: 17627234
[TBL] [Abstract][Full Text] [Related]
17. Tim3/Gal9 interactions between T cells and monocytes result in an immunosuppressive feedback loop that inhibits Th1 responses in osteosarcoma patients.
Li X; Chen Y; Liu X; Zhang J; He X; Teng G; Yu D
Int Immunopharmacol; 2017 Mar; 44():153-159. PubMed ID: 28103502
[TBL] [Abstract][Full Text] [Related]
18. Regulatory T-cell conditioning endows activated effector T cells with suppressor function in autoimmune hepatitis/autoimmune sclerosing cholangitis.
Liberal R; Grant CR; Yuksel M; Graham J; Kalbasi A; Ma Y; Heneghan MA; Mieli-Vergani G; Vergani D; Longhi MS
Hepatology; 2017 Nov; 66(5):1570-1584. PubMed ID: 28597951
[TBL] [Abstract][Full Text] [Related]
19. Serum Th17 cytokines in leprosy: correlation with circulating CD4(+) CD25 (high)FoxP3 (+) T-regs cells, as well as down regulatory cytokines.
Attia EA; Abdallah M; El-Khateeb E; Saad AA; Lotfi RA; Abdallah M; El-Shennawy D
Arch Dermatol Res; 2014 Nov; 306(9):793-801. PubMed ID: 25018055
[TBL] [Abstract][Full Text] [Related]
20. Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease.
Longhi MS; Ma Y; Bogdanos DP; Cheeseman P; Mieli-Vergani G; Vergani D
J Hepatol; 2004 Jul; 41(1):31-7. PubMed ID: 15246204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
